GDF2 and pulmonary arterial hypertension: Beyond its role in cancer, the angiogenic actions of BMP9 have also been explored in other pathologies, including pulmonary arterial hypertension (PAH), a disease of occlusive pulmonary vascular remodeling that is linked to excessive endothelial cell proliferation and loss-of-function mutations in the gene encoding BMPR-II (163).